Helius Medical Technologies Files 8-K
Ticker: HSDT · Form: 8-K · Filed: Sep 22, 2025 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | 8-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure, financial-reporting
TL;DR
Helius Medical filed a routine 8-K on 9/22/25, no major news.
AI Summary
Helius Medical Technologies, Inc. filed an 8-K on September 22, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for the period ending September 22, 2025.
Why It Matters
This 8-K filing serves as a standard disclosure for Helius Medical Technologies, Inc., providing updates on regulatory and financial reporting without detailing specific new material events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information indicating significant new risks or material adverse events.
Key Players & Entities
- Helius Medical Technologies, Inc. (company) — Registrant
- September 22, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 642 Newtown Yardley Road, Suite 100 (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing for Helius Medical Technologies, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits as of September 22, 2025.
On what date was this 8-K report filed or effective?
The report was filed as of September 22, 2025.
In which state is Helius Medical Technologies, Inc. incorporated?
Helius Medical Technologies, Inc. is incorporated in Delaware.
What is the business address of Helius Medical Technologies, Inc. as listed in the filing?
The business address is 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.
Does this filing indicate any specific new material events or financial results?
This filing does not detail specific new material events or financial results beyond the standard reporting categories of Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-09-22 07:22:42
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 HSDT The Nasdaq Stock Market LLC
Filing Documents
- tm2526642d1_8k.htm (8-K) — 25KB
- tm2526642d1_ex99-1.htm (EX-99.1) — 10KB
- 0001104659-25-091854.txt ( ) — 200KB
- hsdt-20250922.xsd (EX-101.SCH) — 3KB
- hsdt-20250922_lab.xml (EX-101.LAB) — 33KB
- hsdt-20250922_pre.xml (EX-101.PRE) — 22KB
- tm2526642d1_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 22, 2025, Helius Medical Technologies, Inc. (the "Company") issued a press release. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Press Release, dated September 22, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 22, 2025 Helius Medical Technologies, Inc. By: /s/ Joseph Chee Name: Joseph Chee Title: Executive Chairman